Ethan Emberley

2.4k total citations
28 papers, 1.4k citations indexed

About

Ethan Emberley is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Ethan Emberley has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Cancer Research and 9 papers in Immunology. Recurrent topics in Ethan Emberley's work include S100 Proteins and Annexins (12 papers), Cancer Research and Treatments (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Ethan Emberley is often cited by papers focused on S100 Proteins and Annexins (12 papers), Cancer Research and Treatments (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Ethan Emberley collaborates with scholars based in Canada, United States and United Kingdom. Ethan Emberley's co-authors include Peter H. Watson, Leigh C. Murphy, Raymond J. Deshaies, Yulian Niu, Linda Snell, Etienne Leygue, Salem Alowami, Anjanabha Saha, Ladislav Tomes and Adrian L. Harris and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Ethan Emberley

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ethan Emberley Canada	19	1.1k	442	297	261	129	28	1.4k
Yulian Niu Canada	18	787 0.7×	346 0.8×	169 0.6×	310 1.2×	100 0.8×	20	1.2k
Linda Snell Canada	12	710 0.6×	341 0.8×	149 0.5×	351 1.3×	100 0.8×	14	1.1k
Eric C. McGary United States	15	628 0.6×	205 0.5×	134 0.5×	480 1.8×	143 1.1×	22	1.1k
Jianhua Ling United States	22	1.2k 1.0×	457 1.0×	402 1.4×	594 2.3×	86 0.7×	28	1.8k
José Grenet United States	19	1.5k 1.3×	394 0.9×	278 0.9×	674 2.6×	108 0.8×	26	1.9k
Young-Jun Jeon South Korea	23	1.6k 1.4×	1.1k 2.6×	129 0.4×	325 1.2×	93 0.7×	45	1.9k
Christelle Benaud France	15	623 0.6×	241 0.5×	160 0.5×	197 0.8×	48 0.4×	21	1.1k
José F. Ruiz Spain	17	1.0k 0.9×	377 0.9×	101 0.3×	171 0.7×	56 0.4×	29	1.4k
Matthew P. Stokes United States	20	1.2k 1.0×	197 0.4×	128 0.4×	395 1.5×	186 1.4×	49	1.6k

Countries citing papers authored by Ethan Emberley

Since Specialization

Citations

This map shows the geographic impact of Ethan Emberley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ethan Emberley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ethan Emberley more than expected).

Fields of papers citing papers by Ethan Emberley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ethan Emberley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ethan Emberley. The network helps show where Ethan Emberley may publish in the future.

Co-authorship network of co-authors of Ethan Emberley

This figure shows the co-authorship network connecting the top 25 collaborators of Ethan Emberley. A scholar is included among the top collaborators of Ethan Emberley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ethan Emberley. Ethan Emberley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Emberley, Ethan, Alison Pan, Jason Chen, et al.. (2021). The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma. PLoS ONE. 16(11). e0259241–e0259241. 33 indexed citations

Works, Melissa, Mark K. Bennett, Ethan Emberley, et al.. (2016). Abstract 552: Immuno-oncology agent CB-1158 is a potent and selective arginase inhibitor and causes an immune-mediated anti-tumor response. Cancer Research. 76(14_Supplement). 552–552. 10 indexed citations

Emberley, Ethan, Mark K. Bennett, Matt Gross, et al.. (2016). CB-839, a selective glutaminase inhibitor, has anti-tumor activity in renal cell carcinoma and synergizes with everolimus and receptor tyrosine kinase inhibitors. European Journal of Cancer. 69. S124–S124. 6 indexed citations

Gross, Matthew, Jason Chen, Ethan Emberley, et al.. (2015). Abstract A195: CB-1158 inhibits the immuno-oncology target arginase and causes an immune mediated anti-tumor response. Molecular Cancer Therapeutics. 14(12_Supplement_2). A195–A195. 4 indexed citations

Emberley, Ethan, et al.. (2012). Deconjugation of Nedd8 from Cul1 Is Directly Regulated by Skp1-F-box and Substrate, and the COP9 Signalosome Inhibits Deneddylated SCF by a Noncatalytic Mechanism. Journal of Biological Chemistry. 287(35). 29679–29689. 103 indexed citations

Deshaies, Raymond J., Ethan Emberley, & Anjanabha Saha. (2010). Control of Cullin-Ring Ubiquitin Ligase Activity by Nedd8. Sub-cellular biochemistry. 54. 41–56. 80 indexed citations

Zhou, Ge, Meina Zhao, S Jasser, et al.. (2008). Reciprocal negative regulation between S100A7/psoriasin and β-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. Oncogene. 27(25). 3527–3538. 49 indexed citations

Skliris, G., Ethan Emberley, Baocheng Peng, et al.. (2006). Estrogen receptor-β regulates psoriasin (S100A7) in human breast cancer. Breast Cancer Research and Treatment. 104(1). 75–85. 28 indexed citations

Kennedy, Richard D., Julia J. Gorski, Jennifer E. Quinn, et al.. (2005). BRCA1 and c-Myc Associate to Transcriptionally Repress Psoriasin, a DNA Damage–Inducible Gene. Cancer Research. 65(22). 10265–10272. 71 indexed citations

10.

Emberley, Ethan, Michael M. Lizardo, Salem Alowami, et al.. (2005). Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis. BMC Cancer. 5(1). 17–17. 33 indexed citations

11.

Emberley, Ethan, Yulian Niu, Sandra Troup, et al.. (2005). The S100A7-c-Jun Activation Domain Binding Protein 1 Pathway Enhances Prosurvival Pathways in Breast Cancer. Cancer Research. 65(13). 5696–5702. 64 indexed citations

12.

Emberley, Ethan, Salem Alowami, Linda Snell, Leigh C. Murphy, & Peter H. Watson. (2004). S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situof the breast. Breast Cancer Research. 6(4). R308–15. 51 indexed citations

13.

Chooniedass‐Kothari, Shilpa, Ethan Emberley, Mohammad K. Hamedani, et al.. (2004). The steroid receptor RNA activator is the first functional RNA encoding a protein. FEBS Letters. 566(1-3). 43–47. 120 indexed citations

14.

Emberley, Ethan, Leigh C. Murphy, & Peter H. Watson. (2004). S100 proteins and their influence on pro-survival pathways in cancer. Biochemistry and Cell Biology. 82(4). 508–515. 116 indexed citations

15.

Emberley, Ethan, Leigh C. Murphy, & Peter H. Watson. (2004). S100A7 and the progression of breast cancer. Breast Cancer Research. 6(4). 153–9. 81 indexed citations

16.

Emberley, Ethan, Leigh C. Murphy, & Peter H. Watson. (2004). Review S100A7 and the progression of breast cancer.

17.

Alowami, Salem, Gefei Qing, Ethan Emberley, Linda Snell, & Peter H. Watson. (2003). Psoriasin (S100A7) expression is altered during skin tumorigenesis. BMC Dermatology. 3(1). 1–1. 76 indexed citations

18.

Emberley, Ethan, Mohammad K. Hamedani, Allen Grolla, et al.. (2003). Identification of new human coding steroid receptor RNA activator isoforms. Biochemical and Biophysical Research Communications. 301(2). 509–515. 66 indexed citations

19.

Tomes, Ladislav, Ethan Emberley, Yulian Niu, et al.. (2003). Necrosis and Hypoxia in Invasive Breast Carcinoma. Breast Cancer Research and Treatment. 81(1). 61–69. 100 indexed citations

20.

Emberley, Ethan, R. Daniel Gietz, John D. Campbell, et al.. (2002). RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer. BMC Cancer. 2(1). 28–28. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact